Related references
Note: Only part of the references are listed.Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2
Adedamola Olayanju et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Cyclin E/Cdk2-dependent phosphorylation of Mcl-1 determines its stability and cellular sensitivity to BH3 mimetics
Gaurav S. Choudhary et al.
ONCOTARGET (2015)
Assessing the Efficacy of Mdm2/Mdm4-Inhibiting Stapled Peptides Using Cellular Thermal Shift Assays
Ban Xiong Tan et al.
SCIENTIFIC REPORTS (2015)
Cancer-Derived Mutations in KEAP1 Impair NRF2 Degradation but not Ubiquitination
Bridgid E. Hast et al.
CANCER RESEARCH (2014)
Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
Shasha Tao et al.
CANCER RESEARCH (2014)
Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis
Zheng-Yu Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Nrf2 Knockout Enhances Intestinal Tumorigenesis in Apcmin Mice Due to Attenuation of Anti-Oxidative Stress Pathway While Potentiates Inflammation
Ka Lung Cheung et al.
MOLECULAR CARCINOGENESIS (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
Tracking cancer drugs in living cells by thermal profiling of the proteome
Mikhail M. Savitski et al.
SCIENCE (2014)
Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction
Longqin Hu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Global Subcellular Characterization of Protein Degradation Using Quantitative Proteomics
Mark Larance et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents
Sadagopan Magesh et al.
MEDICINAL RESEARCH REVIEWS (2012)
Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha
Brian N. Chorley et al.
NUCLEIC ACIDS RESEARCH (2012)
Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks
Yosuke Hirotsu et al.
NUCLEIC ACIDS RESEARCH (2012)
Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs
Xiuwen Tang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo
Kristen L. Meerbrey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
Dongmei Ren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Metabolic Alkene Reporter for Spatiotemporally Controlled Imaging of Newly Synthesized Proteins in Mammalian Cells
Wenjiao Song et al.
ACS CHEMICAL BIOLOGY (2010)
Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis
Deepti Malhotra et al.
NUCLEIC ACIDS RESEARCH (2010)
Inhibitors of translation initiation as cancer therapeutics
Lisa Lindqvist et al.
FUTURE MEDICINAL CHEMISTRY (2009)
RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy
Anju Singh et al.
CANCER RESEARCH (2008)
Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3
Girish Rachakonda et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha
Xiu Jun Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism
Kit I. Tong et al.
BIOLOGICAL CHEMISTRY (2006)
A probability-based approach for high-throughput protein phosphorylation analysis and site localization
Sean A. Beausoleil et al.
NATURE BIOTECHNOLOGY (2006)
Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2
Changjiang Xu et al.
CANCER RESEARCH (2006)
Regularization and variable selection via the elastic net
H Zou et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2005)
Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell line
T Tarumoto et al.
EXPERIMENTAL HEMATOLOGY (2004)
Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation
J Bloom et al.
CELL (2003)
Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress
DD Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice
M Ramos-Gomez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)